Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-737 Cr₹-769 Cr₹-561 Cr₹-1,543 Cr₹-524 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-737 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-737 Cr
Mar2025₹-769 Cr
Mar2024₹-561 Cr
Mar2023₹-1,543 Cr
Mar2022₹-524 Cr

How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-737 Cr
Negative
Mar2025 ₹-769 Cr
Negative
Mar2024 ₹-561 Cr
Negative
Mar2023 ₹-1,543 Cr
Negative
Mar2022 ₹-524 Cr -

Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,830.2 Cr 1.6% -8.6% -7.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

1.6%

-8.6%

-7.6%

SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses